🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cocaine dependence is a major public health problem; an effective primary t...
Status
Completed
Location
University of Texas Health Science Center
Start Date
2000-03
Trial ID
NCT00218075
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
The aims of this proposal include tests of hypotheses of the pathogenetic m...
Status
Unknown
Location
Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital
Start Date
2012-01
Trial ID
NCT02578849
Treatments Being Tested
This phase I trial studies the side effects and best dose of selinexor when...
Status
Completed
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Start Date
2015-06-09
Trial ID
NCT02303392
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
This study will treat patients with advanced NSCLC who have already receive...
Status
Completed
Location
Research Site
Start Date
2013-03-04
Trial ID
NCT01802632
Treatments Being Tested
This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Status
Recruiting
Location
Maryland Oncology Hematology
Start Date
2023-07-24
Trial ID
NCT05748834
The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Status
Recruiting
Location
Mayo Clinic Cancer Center
Start Date
2026-06-12
Trial ID
NCT07104032
Treatments Being Tested